Sen.
Passing legislation to address drug costs is challenging because of the pharmaceutical industry’s lobbying influence, but Congress could make inroads by harnessing public scrutiny, Sanders (I-Vt.) said Thursday at a press conference.
“One of the tools we have is public pressure,” Sanders said. “When the American people know what’s going on, it puts pressure on them that helps us lower the cost.”
The CEOs of
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.